Directly supplementing can help bridge that gap
Start with simple applications, monitor your skin's response, and adjust as needed
For further prognostic evaluation and clinical decision-making, breast cancer can be classified into three subgroups based on immunohistochemical staining results for ER, PR, and HER2: HR-positive/HER2negative (HR+/HER2, ~70%), HER2positive (HER2+, ~1520%), and triple-negative breast cancer [TNBC, HR-negative (HR-), HER2, ~15%]
Particular attention should be given to understanding all sources of PBM compensation, including rebates, spread pricing, manufacturer payments, and affiliated revenue streams, as well as the potential impact of a broader shift toward more transparent, fee-based compensation models
Methods Study design and setting This was a multicenter retrospective cohort study conducted across tertiary care hospitals in Saudi Arabia, including Ministry of National Guard Health Affairs (MNGHA) medical cities in Riyadh, Jeddah, and Al-Ahsa